|
SMURF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.496200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.647410E-01 |
| Normal-vs-Stage2 |
4.737600E-02 |
| Normal-vs-Stage3 |
4.897000E-01 |
| Normal-vs-Stage4 |
7.901600E-01 |
| Stage1-vs-Stage2 |
1.080400E-03 |
| Stage1-vs-Stage3 |
6.589800E-01 |
| Stage1-vs-Stage4 |
1.462400E-01 |
| Stage2-vs-Stage3 |
1.678050E-02 |
| Stage2-vs-Stage4 |
1.277240E-01 |
| Stage3-vs-Stage4 |
3.915600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.666800E-01 |
| Normal-vs-AfricanAmerican |
5.053800E-01 |
| Normal-vs-Asian |
2.955800E-01 |
| Caucasian-vs-AfricanAmerican |
9.991400E-01 |
| Caucasian-vs-Asian |
7.001800E-01 |
| AfricanAmerican-vs-Asian |
7.959000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.610400E-01 |
| Normal-vs-Female |
3.143400E-01 |
| Male-vs-Female |
2.955200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.169700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.843000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.883180E-01 |
| Normal-vs-Age(81-100Yrs) |
6.026400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.641500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.845100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.721600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.288030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.815200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.712800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.137000E-01 |
| Classical-VS-Follicular |
1.63224989080391E-12 |
| Classical-VS-Other |
6.987600E-01 |
| Classical-VS-Normal |
1.800280E-02 |
| Tall-VS-Follicular |
1.044070E-03 |
| Tall-VS-Other |
6.950400E-01 |
| Tall-VS-Normal |
2.020800E-01 |
| Follicular-VS-Other |
2.174100E-02 |
| Follicular-VS-Normal |
4.29090000000354E-05 |
| Other-VS-Normal |
6.578600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.929800E-01 |
| Normal-vs-N1 |
4.531400E-01 |
| N0-vs-N1 |
1.629970E-01 |
|
|
